Wen-Chien Cheng (Chih-Yen Tu)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 10

Top Topics

Chronic Obstructive Pulmonary Disease

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Canadian respiratory journal

International journal of chronic obstructive pulmonary disease

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Chuan Lin, Mei-Chih Chen, Shi-Wei Huang, Yeh Chen, Jennifer Hui-Chun Ho, Fang-Yu Lin, Xiao-Tong Tan, Hung-Che Chiang, Chiu-Ching Huang, Wen-Chien Cheng, Der-Yang Cho, Shao-Chih Chiu
Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Wen-Chien Cheng, Te-Chun Hsia, Ying-Chun Lin, Ji-An Liang, Chia-Chin Li, Chun-Ru Chien
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors. Canadian respiratory journal 2024 (2024)
Wen-Chien Cheng, Te-Chun Hsia, Ying-Chun Lin, Ji-An Liang, Chia-Chin Li, Chun-Ru Chien
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors. Canadian respiratory journal 2024 (2024)
Khuong T L Nguyen, Jhih-Yi Chiou, You-Chi Liu, Fang-Ju Cheng, Yi-Cheng Shen, Chao-Jung Chen, Chih-Hsin Tang, Wei-Chien Huang, Chia-Hung Chen, Wen-Chien Cheng
l-lactic acidosis confers insensitivity to PKC inhibitors by competing for uptake via monocarboxylate transporters. Journal of cellular physiology (2021)
Wen-Chien Cheng, Te-Chun Hsia, Chih-Yen Tu, Hung-Jen Chen
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy. OncoTargets and therapy 13 (2021)
Chia-Hung Chen, Bo-Wei Wang, Yu-Chun Hsiao, Chun-Yi Wu, Fang-Ju Cheng, Te-Chun Hsia, Chih-Yi Chen, Yihua Wang, Zhang Weihua, Ruey-Hwang Chou, Chih-Hsin Tang, Yun-Ju Chen, Ya-Ling Wei, Jennifer L Hsu, Wen-Chien Cheng, Mien-Chie Hung, Wei-Chien Huang
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs. Oncogene 40 (29) (2021)
Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao, Biing-Ru Wu, Wei-Chun Chen, Chih-Yen Tu, Chia-Hung Chen, Wen-Chien Cheng
A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease 16 (2021)
Fang-Ju Cheng, Chia-Hung Chen, Wen-Chen Tsai, Bo-Wei Wang, Meng-Chieh Yu, Te-Chun Hsia, Ya-Ling Wei, Yu-Chun Hsiao, Dai-Wei Hu, Chien-Yi Ho, Tzong-Shiun Li, Chun-Yi Wu, Wen-Yu Chou, Han-Chung Lee, Chih-Hsin Tang, Chih-Yi Chen, Chuan-Mu Chen, Jennifer L Hsu, Hsiao-Fan Chen, Yeh Chen, Wen-Chien Cheng, Mien-Chie Hung, Wei-Chien Huang
Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC. Oncogene 40 (6) (2020)
Wen-Chien Cheng, Biing-Ru Wu, Wei-Chih Liao, Chih-Yu Chen, Wei-Chun Chen, Te-Chun Hsia, Chih-Yen Tu, Chia-Hung Chen, Wu-Huei Hsu
When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment. International journal of chronic obstructive pulmonary disease 15 (2020)
Chia-Hung Chen, Wen-Chien Cheng, Biing-Ru Wu, Chih-Yu Chen, Wei-Chun Chen, Wei-Chih Liao, Wen-Chien Cheng
Feasibility and Safety of Pleuroscopic Cryobiopsy of the Pleura: A Prospective Study. Canadian respiratory journal 2018 (2018)
Wen-Chien Cheng, Chia-Hung Chen, Te-Chun Hsia, Min-Hsiang Hsu, Ya-Ling Wei, Meng-Chieh Yu, Wen-Shu Chen, Ke-Wei Hsu, Ming-Hsin Yeh, Liang-Chih Liu, Yun-Ju Chen, Wei-Chien Huang
Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells. BioMed research international 2014 (2014)